Inventor · disambiguated record
David Andrew Wyatt
Also filed as: WYATT DAVID · WYATT DAVID A · WYATT DAVID ANDREW
22 granted patents·9 pending applications·1,513 citations·filing 1987–2022
97Inventor score
Top patents by PatentIndex Score
31 records- 0196US6303103B1Aerosols containing salmeterol xinafoate and an anticholinergic medicamentGLAXO GROUP LTD·Filed 2000·Granted Oct 16, 2001·45 cites·13 claims
- 0296US5674472ACanisters containing aerosol formulations containing P134a and fluticasone propionateGLAXO GROUP LTD·Filed 1995·Granted Oct 7, 1997·127 cites·44 claims
- 0396US5658549AAerosol formulations containing propellant 134a and fluticasone propionateGLAXO GROUP LTD·Filed 1995·Granted Aug 19, 1997·218 cites·39 claims
- 0494US5683676ACanister containing aerosol formulations containing P134a and particulate medicamentsGLAXO GROUP LTD·Filed 1995·Granted Nov 4, 1997·136 cites·32 claims
- 0593US6306369B1Aerosol formulations containing P134a and particulate medicamentGLAXO GROUP LTD·Filed 2000·Granted Oct 23, 2001·31 cites·20 claims
- 0693US6251368B1Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactantGLAXO GROUP LTD·Filed 1997·Granted Jun 26, 2001·75 cites·13 claims
- 0793US5676929ACanister containing aerosol formulations containing P134a and particulate medicamentsGLAXO GROUP LTD·Filed 1995·Granted Oct 14, 1997·85 cites·30 claims
- 0892US5736124AAerosol formulations containing P134a and particulate medicamentGLAXO GROUP LTD·Filed 1995·Granted Apr 7, 1998·122 cites·43 claims
- 0991US6333023B1Aerosol formulation containing particulate formoterol, propellant and polar cosolventGLAXO GROUP LTD·Filed 2000·Granted Dec 25, 2001·22 cites·16 claims
- 1091US5674471AAerosol formulations containing P134a and salbutamolGLAXO GROUP LTD·Filed 1995·Granted Oct 7, 1997·110 cites·51 claims
- 1191US5653962AAerosol formulations containing P134a and particulate medicamentsGLAXO GROUP LTD·Filed 1995·Granted Aug 5, 1997·94 cites·39 claims
- 1290US5744123AAerosol formulations containing P134a and particulate medicamentsGLAXO GROUP LTD·Filed 1995·Granted Apr 28, 1998·102 cites·17 claims
- 1388US5916540AAerosol formulations containing P134A and/or P227 and particulate medicamentGLAXO GROUP LTD·Filed 1998·Granted Jun 29, 1999·57 cites·102 claims
- 1487US6238647B1Aerosol formulations containing salmeterol xinafoate, an anticholinergic agent and tetrafluoroethaneGLAXO GROUP LTD·Filed 1999·Granted May 29, 2001·45 cites·13 claims
- 1587US5922306AAerosol formulations containing P134a and particulate medicamentGLAXO GROUP LTD·Filed 1998·Granted Jul 13, 1999·51 cites·34 claims
- 1683US5817293ACanister containing aerosol formulations containing P134a and particulate medicamentsGLAXO GROUP LTD·Filed 1995·Granted Oct 6, 1998·56 cites·51 claims
- 1782US6200549B1Aerosol formulation containing P134a and particulate medicamentGLAXO GROUP LTD·Filed 1999·Granted Mar 13, 2001·38 cites·27 claims
- 1880US6919069B2Aerosol formulation containing particulate formoterol, propellant and polar cosolventGLAXO GROUP LTD·Filed 2003·Granted Jul 19, 2005·5 cites·43 claims
- 1979US6221339B1MedicamentsGLAXO GROUP LTD·Filed 1999·Granted Apr 24, 2001·32 cites·16 claims
- 2079US4863073AValve for aerosol containerGLAXO GROUP LTD·Filed 1987·Granted Sep 5, 1989·59 cites·4 claims
- 2178US2009188491A1MedicamentsGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 2275US6893628B2Aerosol formulations containing P134a and particulate medicamentGLAXO GROUP LTD·Filed 2003·Granted May 17, 2005·2 cites·43 claims
- 2373US7498020B2MedicamentsGLAXO GROUP LTD·Filed 2004·Granted Mar 3, 2009·1 cites·16 claims
- 2466US2005207991A1Aerosol formulations containing P134a and particulate medicamentGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2566US2005232873A1Aerosol formulation containing particulate formoterol, propellant and polar cosolventGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2666US2004136920A1MedicamentsGLAXO GROUP LTD·Filed 2003·Application pending·0 cites
- 2764US2003143163A1MedicamentsGLAXO GROUP LTD·Filed 2003·Application pending·0 cites
- 2861US2025011773A1Compositions and methods for treating tdp-43 proteinopathyMAZE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2960US2002058011A1Aerosol formulation containing particulate formoterol, propellant and polar cosolventGLAXO GROUP LTD·Filed 2001·Application pending·0 cites
- 3059US2002028183A1MedicamentsGLAXO GROUP LTD·Filed 2001·Application pending·0 cites
- 3159US2002031479A1MedicamentsGLAXO GROUP LTD·Filed 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →